Literature DB >> 21179630

Aripiprazole augmentation of clozapine: in refractory schizophrenia.

Adam Keller Ashton1.   

Abstract

Entities:  

Year:  2005        PMID: 21179630      PMCID: PMC3004715     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


× No keyword cloud information.
  6 in total

1.  An open trial of risperidone augmentation of partial response to clozapine.

Authors:  C G Taylor; S W Flynn; S Altman; T Ehmann; G W MacEwan; W G Honer
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

2.  Ziprasidone augmentation of clozapine in 11 patients.

Authors:  Neil S Kaye
Journal:  J Clin Psychiatry       Date:  2003-02       Impact factor: 4.384

3.  Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.

Authors:  S Raskin; G Katz; Z Zislin; H Y Knobler; R Durst
Journal:  Acta Psychiatr Scand       Date:  2000-04       Impact factor: 6.392

4.  Risperidone augmentation of clozapine.

Authors:  R H McCarthy; K G Terkelsen
Journal:  Pharmacopsychiatry       Date:  1995-03       Impact factor: 5.788

5.  Olanzapine augmentation of clozapine.

Authors:  S Gupta; S J Sonnenberg; B Frank
Journal:  Ann Clin Psychiatry       Date:  1998-09       Impact factor: 1.567

Review 6.  A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation.

Authors:  S M Stahl; M M Grady
Journal:  Curr Med Chem       Date:  2004-02       Impact factor: 4.530

  6 in total
  2 in total

1.  Role of aripiprazole in treatment-resistant schizophrenia.

Authors:  Nilufar Mossaheb; Rainer M Kaufmann
Journal:  Neuropsychiatr Dis Treat       Date:  2012-05-29       Impact factor: 2.570

2.  Clozapine-induced stuttering in the absence of known risk factors: a case report.

Authors:  Florence Jaguga
Journal:  J Med Case Rep       Date:  2021-04-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.